Matches in Wikidata for { <http://www.wikidata.org/entity/Q89506972> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q89506972 description "clinical trial" @default.
- Q89506972 description "ensayo clínico" @default.
- Q89506972 description "ensayu clínicu" @default.
- Q89506972 description "klinisch onderzoek" @default.
- Q89506972 description "клінічне випробування" @default.
- Q89506972 name "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 name "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 name "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 type Item @default.
- Q89506972 label "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 label "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 label "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 prefLabel "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 prefLabel "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 prefLabel "Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 P1132 Q89506972-8FC1B890-6437-44B5-9745-B673A26584A2 @default.
- Q89506972 P1476 Q89506972-59E55086-12EA-4C4A-837D-A0F4ADC8B443 @default.
- Q89506972 P17 Q89506972-87ECBA03-750F-4083-AADD-5A0BD75B029B @default.
- Q89506972 P1813 Q89506972-DE596D17-EB83-4A48-B1C0-0BA6A98E59A6 @default.
- Q89506972 P2899 Q89506972-9FCBE8BB-1BDC-4DDB-A5AB-C23F05F27AEF @default.
- Q89506972 P3098 Q89506972-8363B050-4D5C-4369-B18E-5B8592D7C510 @default.
- Q89506972 P31 Q89506972-1C35AD20-E4AC-41A6-89AE-BA0F8691CB84 @default.
- Q89506972 P4844 Q89506972-320B9451-8B0C-429F-AAE9-8022D67461E4 @default.
- Q89506972 P4844 Q89506972-37208D0D-BB3C-47F2-8CDD-80F54076D752 @default.
- Q89506972 P4844 Q89506972-93C8FA1A-150B-4A71-8056-D63A997E065E @default.
- Q89506972 P580 Q89506972-D8ECBA5C-BE0B-4CC1-A3C9-56144A7DE4D1 @default.
- Q89506972 P582 Q89506972-3DB56A00-AFC0-4531-85B7-9AD976DF6694 @default.
- Q89506972 P6099 Q89506972-12AC6F96-F41D-46B9-8FC7-29D5BA308EA8 @default.
- Q89506972 P8363 Q89506972-65DA3E4B-1FAB-409E-9E4E-125999DF7B4B @default.
- Q89506972 P921 Q89506972-0035F4C0-D9AB-4E77-B336-EB0A9E163C6E @default.
- Q89506972 P921 Q89506972-D6C78D76-1AB4-4C3C-8737-561250651880 @default.
- Q89506972 P1132 "+273" @default.
- Q89506972 P1476 "A Prospective, Controlled, Randomized, Multicenter Study to Compare the Efficacy of a Chloroquine Analog (GNS561), an Anti PD-1 (Nivolumab) and an Anti-interleukine-6 Receptor (Tocilizumab) Versus Standard of Care in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection" @default.
- Q89506972 P17 Q142 @default.
- Q89506972 P1813 "IMMUNONCOVID" @default.
- Q89506972 P2899 "+18" @default.
- Q89506972 P3098 "NCT04333914" @default.
- Q89506972 P31 Q30612 @default.
- Q89506972 P4844 Q422438 @default.
- Q89506972 P4844 Q56363387 @default.
- Q89506972 P4844 Q7041828 @default.
- Q89506972 P580 "2020-04-01T00:00:00Z" @default.
- Q89506972 P582 "2020-06-01T00:00:00Z" @default.
- Q89506972 P6099 Q42824440 @default.
- Q89506972 P8363 Q78089383 @default.
- Q89506972 P921 Q82069695 @default.
- Q89506972 P921 Q84263196 @default.